# A Single and Multiple Ascending Dose Study of COR588

> **NCT04920903** · PHASE1 · COMPLETED · sponsor: **Cortexyme Inc.** · enrollment: 64 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** COR588
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04920903
- **Lead sponsor:** Cortexyme Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-26
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04920903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04920903, "A Single and Multiple Ascending Dose Study of COR588". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04920903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*